Revance Therapeutics, Inc. ("Revance") is a pharmaceutical company focused on aesthetic and therapeutic offerings.

According to the Complaint, on or about June 6, 2014, Revance filed with the SEC its registration statement, which, following amendment and being declared effective by the SEC on June 18, 2014, would later be utilized for the Offering. The Complaint alleges the Registration Statement was negligently prepared and, as a result, contained untrue statements of material facts or omitted to state other facts necessary to make the statements made not misleading, and was not prepared in accordance with the rules and regulations governing its preparation.

On August 31, 2015, the Court issued an Order granting Plaintiff's motion to remand to the Superior Court of the State of California for the County of San Mateo.